TABLE 2. Demographic characteristics of patients with confirmed Legionnaires’ disease*— 21 U.S. public health jurisdictions,† 2015.
| Characteristic | No. cases (%) |
|||
|---|---|---|---|---|
| Definite health care–associated (n = 85) |
Possible health care–associated (n = 468) | Not health care–associated (n = 2,256) |
||
|
Age group (yrs)
| ||||
| 0–29 |
0 (0) |
16 (3.4) |
59 (2.6) |
|
| 30–39 |
1 (1.2) |
10 (2.1) |
148 (6.6) |
|
| 40–49 |
2 (2.4) |
35 (7.5) |
322 (14.3) |
|
| 50–59 |
7 (8.2) |
111 (23.7) |
596 (26.4) |
|
| 60–69 |
18 (21.2) |
125 (26.7) |
557 (24.7) |
|
| 70–79 |
23 (27.1) |
88 (18.8) |
321 (14.2) |
|
| 80–89 |
18 (21.2) |
67 (14.3) |
197 (8.7) |
|
| ≥90 |
16 (18.8) |
15 (3.2) |
53 (2.4) |
|
| Unknown |
0 (0) |
1 (0.2) |
3 (0.1) |
|
|
Sex
|
|
|||
| Male |
40 (47.1) |
263 (56.2) |
1,419 (62.9) |
|
| Female |
45 (52.9) |
200 (42.7) |
820 (36.4) |
|
| Unknown |
0 (0) |
5 (1.1) |
17 (0.8) |
|
|
Race
|
|
|||
| Black or African American |
16 (18.8) |
91 (19.4) |
598 (26.5) |
|
| White |
53 (62.3) |
315 (67.3) |
1,373 (60.9) |
|
| Asian |
0 (0 ) |
5 (1.1) |
20 (0.9) |
|
| American Indian/Alaska Native |
0 (0) |
2 (0.4) |
12 (0.5) |
|
| Native Hawaiian/Pacific Islander |
0(0) |
1(0.2) |
3(0.1) |
|
| Multiple |
1 (1.2) |
0 (0) |
0 (0) |
|
| Unknown |
15 (17.7) |
54 (11.5) |
250 (11.1) |
|
|
Ethnicity
|
|
|||
| Hispanic |
3 (3.5) |
29 (6.2) |
159 (7.1) |
|
| Non-Hispanic |
65 (76.5) |
338 (72.2) |
1,673 (74.2) |
|
| Unknown | 17 (20.0) |
101 (21.6) | 424 (18.8) | |
* Definite health care–associated Legionnaires’ disease was defined as laboratory-confirmed legionellosis in a patient with continuous exposure to a hospital or long-term care facility for the entire 10 days preceding symptom onset. Possible health care–associated Legionnaires’ disease was defined as laboratory-confirmed legionellosis in a patient with any exposure to a health care facility for a portion of the 10 days preceding symptom onset. All other cases were considered not health care–associated.
† Twenty-one jurisdictions that reported ≥90% of confirmed National Notifiable Diseases Surveillance System legionellosis cases to the Supplemental Legionnaires’ Disease Surveillance System in 2015: Alabama, Colorado, Connecticut, Georgia, Hawaii, Iowa, Kentucky, Maine, Michigan, Minnesota, Missouri, New Hampshire, New Mexico, New York, New York City, North Dakota, Ohio, Rhode Island, South Carolina, Texas, and Virginia.